Note

pubs.acs.org/joc

Chiral Bifunctional Guanidine-Catalyzed Enantioselective Aza-Henry
Reaction of Isatin-Derived Ketimines
Bing Fang, Xiaohua Liu,* Jiannan Zhao, Yu Tang, Lili Lin, and Xiaoming Feng*
Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu
610064, P. R. China
*S Supporting Information

ABSTRACT: An eﬃcient asymmetric aza-Henry reaction of
isatin-derived ketimines has been achieved by using a chiral
guanidine−amide organocatalyst. A series of 3-substituted 3-
amino-2-oxindoles was obtained with excellent results (up to
99% yield, 94% ee). Other functionalized derivatives were also
conveniently transformed. This metal-free system was conven-
ient, practical, and insensitive to air and moisture. On the basis
of the crystal structure of the catalyst and NMR spectra analysis,
a bifunctional catalytic model was suggested to explain the origin
of the asymmetric process.

G uanidines, owing to their prominent role in organo-

catalysis,1 have attracted increasing attention during the
past two decades. Their characteristics of strong Brønsted
basicity and molecular recognition through hydrogen bonds2,3
suggest
to be used as chiral bifunctional
organocatalysts.4 Since Nájera et al. reported the ﬁrst chiral
guanidine in asymmetric organocatalytic Henry reaction,5a a
number of chiral guanidine and guanidium salt catalysts5 have
been developed. They are demonstrated eﬃcient for asym-
metric reactions, such as Michael reaction,5b,c Henry reaction,5d
Mannich reaction,5e and others. Our group designed bifunc-
tional acyclic guanidine and bisguanidine catalysts which are
easily accessible from chiral α-amino acids.6a They are
convenient
the
amino acid backbone, the amide moiety, and the amidine unit
can be ﬁne-tuned. We have dedicated ourselves to the
development of such a chiral guanidine catalyst library and
have disclosed several eﬃcient asymmetric reactions.6 In view

the potential

for manipulation. As shown in Figure 1,

of the previous studies relating to the guanidine-promoted
Henry reactions,5a,d we envisioned that our bifunctional
guanidines could be utilized in the aza-Henry reaction of
isatin-derived ketimines.

The asymmetric aza-Henry reaction,7 an eﬃcient method for
the synthesis of β-nitro amines, is among the most powerful
C−C bond formation methodologies. Despite the abundant
examples of enantioselective aza-Henry reaction with aldi-
mines,8 the situation in which ketimines are employed as the
electrophiles is rarely reported9 due to their low reactivity and
the diﬃculty in enantioface diﬀerentiation. The aza-Henry
reaction of isatin-derived ketimines is an eﬃcient way to obtain
privileged oxindole skeletons bearing a stereogenic center at the
C3-position.10 The resulting 3-amino-2-oxindole framework has
been recognized as a core structure in pharmaceutical building
blocks and alkaloid natural products.10a Several catalytic
systems have been developed for their asymmetric synthesis.11
−PyBidine complex and
Two chiral metal complexes, the NiCl2
−BOX complex have been used in the
the Cu(BF4)2
enantioselective aza-Henry reactions of isatin-derived ketimines
by Arai’s12a and Pedro’s12b groups, respectively. A catalytic
amount of an achiral organic base was used to deprotonate the
nitroalkanes for nucleophilic addition. Chiral organic base
catalysts seem to be an ideal alternative to chiral metal-based
catalysts, which could simplify the catalytic system. Zhou’s
group explored a quinine-derived bifunctional organocatalyst
for this reaction, resulting in moderate to good enantiose-
lectivities.13 Using a cinchona alkaloid organocatalyst, Chimni
and co-workers14 realized this reaction with only moderate
yields and enantioselectivities. In an attempt to identify the
basicity of our guanidine catalyst and to expand the substrate

Figure 1. Chiral guanidines employed for the aza-Henry reaction.

Received:
January 12, 2015
Published: February 27, 2015

© 2015 American Chemical Society

3332

DOI: 10.1021/acs.joc.5b00075
J. Org. Chem. 2015, 80, 3332−3338

The Journal of Organic Chemistry

scope in an organocatalytic version, we initiated studies for an
eﬃcient and convenient asymmetric aza-Henry reaction
promoted by a chiral guanidine organocatalyst. Excellent
enantioselectivities were achieved for a wide range of ketimines
derived from isatins.
<para sub=“opt”>
We began with a screen of several chiral guanidine catalysts
for the addition of nitromethane to the isatin-derived N-Boc
ketimine 2a in toluene at 30 °C. Chiral guanidines 1 bearing
diﬀerent amino amide backbones all provided complete
conversion to the adduct 3a with varying enantioselectivities
(Table 1, entries 1−3). The L-pipecolic acid derivative 1c was
</para>
Table 1. Optimization of the Reaction Conditions of the
Aza-Henry Reaction

entrya
1
2
3
4
5
6
7
8
9
10d
11d,e

cat.
1a
1b
1c
1d
1e
1d
1d
1d
1d
1d
1d

x

18.0
18.0
18.0
18.0
18.0
9.0
4.5
9.0
9.0
9.0
9.0

temp (°C)

time (h)

yieldb (%)

eec (%)

30
30
30
30
30
30
30
0
−30
−30
−30

24
24
24
24
24
24
24
36
72
72
72

99
99
99
99
99
99
91
99
99
99
99

31
17
56
79
50
83
83
87
91
94
94

aUnless otherwise noted, the reactions was performed with 2a (0.1
mmol) and 1 (10 mol %) in toluene (1.0 mL) under N2. bIsolated
yield. cDetermined by chiral HPLC analysis. d4 Å MS (10.0 mg) was
added. eThe reaction was carried out under an air atmosphere.
<para sub=“opt”>
superior to (S)-tetrahydroisoquinoline-3-carboxylic acid and L-
proline-derived catalysts 1a and 1b, giving the adduct 3a in 99%
yield with 56% ee. When the amide unit was changed from the
diphenylmethyl group to the more sterically hindered
the guanidine 1d showed more
triphenylmethyl group,
promising results (79% ee; Table 1, entry 4 vs entry 3). But
guanidine 1e bearing two isopropyl substituents on the amidine
unit resulted in a lower enantioselectivity (50% ee; Table 1,
entry 5). Halving the molar equivalents of nitromethane, which
was supposed to minimize a possible nonenantioselective
background reaction, resulted in a superior enantioselectivity
(83% ee), but further decreasing the amount of nitromethane
led to an obvious drop in the yield without any improvement in
the enantioselectivity (Table 1, entry 6 vs entries 4 and 7).
Furthermore, cooling the reaction temperature to −30 °C
beneﬁted the stereocontrol (91% ee), although a longer
reaction time was required (Table 1, entry 9). In order to
improve the results, an additive investigation was carried out,
and it showed that 4 Å MS could enhance the enantioselectivity
to 94% ee (Table 1, entry 10). Notably, the reaction system was
insensitive to air and moisture, which made the operation
convenient (Table 1, entry 11).
</para>
<para sub="scope">
Having identiﬁed suitable reaction conditions, we next
evaluated the reactions of various substituted isatin-derived
ketimines 2 (Scheme 1). The results revealed that the steric
nature of the N-alkoxycarbonyl groups of the imine unit had a
</para>
Note
<para sub="scope">
slight inﬂuence on the enantioselectivity. When the N-Boc
group was changed into an N-CO2Et or N-Cbz group, the
corresponding ketimines were smoothly converted into the
adducts with 85% ee and 86% ee, respectively (see 3b and 3c).
When the N-benzyl protective group at the isatin framework
was replaced by an N-methyl group, the yield decreased to 81%
and the ee value to 86% (see 3d). Next, we applied the catalytic
system to diﬀerent N-Boc-ketimines to deﬁne the scope of this
aza-Henry reaction. A variety of electronic diverse substituents
on the aromatic ring of the substrates were tested. To our
delight, excellent yields (85−99%) and enantioselectivities
(89−94% ee) were obtained (see 3e−q) for a selection of
electron-donating and -withdrawing substituents. The results
indicated that the position of the substituent had an obvious
eﬀect on the reactivity. For example, the ketimines containing a
Cl or Br atom at the C6-position showed higher reactivity (see
3k and 3l) than the substrates with the same substituents at the
5- or 7-position (see 3f, 3g, 3n, and 3o). An eﬀect of the
electronic property of the substituents was also observed. A
general trend observed was the prolonging of the reaction time
upon changing from an electron-withdrawing group at the 5-
position to electron-donating ones (see 3e, 3i, 3j, and 3q). The
conditions were also appropriate for the reaction of nitro-
ethane, and both diastereomers were obtained in a highly
enantioselective manner, albeit with low diastereoselectivity
(65/35 dr; see 3r).
</para>
<para sub=“props”>
To explore the synthetic potential of the current catalytic
system, the reaction was scaled up to a gram-scale. Under the
optimal conditions, 3 mmol of isatin-derived N-Boc ketimine
2a reacted with nitromethane smoothly, giving the adduct 3a in
99% yield with 94% ee. An X-ray study of enantiomerically pure
aza-Henry product 3a shows the R absolute conﬁguration.15
The product 3a could facilitate further
transformations
eﬃciently (Scheme 2). Deprotection of the N-Boc group was
achieved in excellent yield with the enantioselectivity kept. The
nitro group was reduced by NaBH4/NiCl2,16 giving the
monoprotected diamines 5 in 91% yield and 94% ee. On the
other hand, nitrile 6, which is of great synthetic potential,17 was
obtained through two steps in 75% yield and 93% ee.
</para>
<para sub=“props”>
The X-ray structure of the guanidine 1d (Figure 2)15 showed
an intramolecular hydrogen bond formed between the imine
and amide of the catalyst. A comparison with the similar
guanidine-amide 1f,18 bearing 2,6-diisopropylaniline substitu-
tion,6a showed an obvious spatial change of the amidine unit.
The torsions angle between the NH bond and the CN bond
altered upon the variation of the amide (1d, 101.77° vs 1f,
10.21°). This indicates that the NH bond of 1d favors an
orthogonal arrangement with respect to the amidine unit. Next,
the interaction between the guanidine catalyst 1d and
nitroalkane was conﬁrmed from an 1H NMR study. When
nitroethane was added to the solution of the guanidine 1d in
CDCl3 or DMSO-d6, the integration of the HN peak of the
amide (δ 10.59 in CDCl3 and δ 3.30 in DMSO-d6) decreases
signiﬁcantly, indicating the breaking of the intramolecular N−H
bond. The CH2 group of nitroethane resonates at a slightly
higher ﬁeld strength (δ 4.43 vs δ 4.41 in CDCl3). The CH2
peak is less than 2/3 the area of the CH3 peak, indicating that
deprotonation of
the guanidine from the nitroethane had
occurred.
</para>
<para sub="scope">
Therefore, a bifunctional catalytic model was suggested to
rationalize the observed enantioselection (Figure 2). First, the
guanidine deprotonates an active hydrogen from the nitro-
alkane to form a guanidium cation.
It would bond the
</para>
3333

DOI: 10.1021/acs.joc.5b00075
J. Org. Chem. 2015, 80, 3332−3338

The Journal of Organic Chemistry

Note

Scheme 1. Substrate Scope of the Catalytic Asymmetric Aza-Henry Reaction

Scheme 2. Transformations of the Adduct 3aa

aReaction conditions: (a) CF3CO2H, 0 °C, then K2CO3; (b) NaBH4,
NiCl2, MeOH, 0 °C; (c) SnCl2
·2H2O, PhSH, Et3N, EtOH, then
SOCl2, Et3N, THF.
<para sub="scope">
nucleophile in a dual hydrogen-bonding manner. The amide
unit rotates outwardly when the intramolecular hydrogen-
bonding disappears.6f Then, the amide could act as a Brønsted
acid to activate ketimine 2a through an intermolecular
hydrogen bonding. One face of the ketimine is shielded by
the phenyl groups of the amide unit, and the nucleophile
</para>
Figure 2. Proposed catalytic model based on the X-ray structure of the
catalyst.
<para sub="scope">
attacks the ketimine from the Re-face,
product 3a.
</para>
leading to the (R)-

In conclusion, we have developed an organocatalytic
procedure for the asymmetric aza-Henry reaction of
isatin-
derived ketimines. In the presence of a bifunctional guanidine
catalyst, this process aﬀorded the desired adducts in high
enantioselectivity and yield. A range of substrates could tolerate
well in the reaction. Further application of the chiral guanidine-
amide catalysts in asymmetric transformations are undergoing
in our group.

■ EXPERIMENTAL SECTION
<para sub=“exp”>
General remarks. Reactions were carried out using commercially
available reagents in an oven-dried apparatus. Toluene was dried over
Na and distilled before use. Nitromethane was dried over anhydrous
</para>
3334

DOI: 10.1021/acs.joc.5b00075
J. Org. Chem. 2015, 80, 3332−3338

The Journal of Organic Chemistry

Note
<para sub=“exp”>
CaCl2 and distilled prior to use. Enantiomeric excesses (ee) were
determined by HPLC analysis using the corresponding commercial
chiral column as stated in the experimental procedures at 23 °C with
UV detection at 254 nm. Optical rotations were reported as follows:
[α]D
T (c: g/100 mL, in solvent).1H NMR spectra were recorded on
commercial instruments (400 MHz). 13C NMR spectra were collected
on commercial
instruments (100 MHz) with complete proton
decoupling.

General Procedure for the Catalytic Asymmetric Aza-Henry
Reaction. To a stirred solution of ketimine 2a (0.10 mmol, 33.6 mg),
guanidine catalyst 1d (10 mol %, 0.01 mmol, 5.8 mg), and 4 Å MS in
toluene (1.0 mL) was added nitromethane (9.0 equiv, 50 μL) at −30
°C. After being stirred for 72 h, the residue was directly puriﬁed by
column chromatography on silica gel (pet/EtOAc = 6/1 as the eluent)
to aﬀord 3a as a white solid (99% yield, 39.6 mg, 94% ee). The
enantiomeric excess (ee) was determined by high-performance liquid
chromatography (HPLC).
Guanidine 1d. Compound 1d was synthesized according to the
literature.6a White solid: mp 178−180 °C; 1H NMR (CDCl3) δ 10.59
(s, 1H), 7.32−7.12 (m, 15H), 4.38 (d, J = 4.0 Hz, 1H), 3.44 (d, J =
13.2 Hz, 1H), 3.21 (d, J = 10.0 Hz, 1H), 3.03−2.841 (m, 1H), 2.84−
2.59 (m, 2H), 2.16 (d, J = 12.4 Hz, 1H), 1.99−0.84 (m, 25H), 0.46−
0.25 (m, 1H); 13C NMR (CDCl3) δ 172.7, 172.6, 155.8, 155.7, 145.5,
145.5, 129.1, 127.6, 126.2, 70.2, 70.2, 57.3, 56.3, 54.0, 53.9, 45.4, 35.6,
35.0, 33.9, 33.8, 26.4, 25.9, 25.7, 25.5, 25.4, 25.4, 25.3, 21.6; HRMS
(ESI-TOF) calcd for C38H49N4O ([M + H+]) = 577.3901, found
577.3909; IR (KBr) ν = 3398, 3142, 3085, 3057, 3024, 2929, 2850,
1946, 1874, 1802, 1690, 1605, 1544, 1490, 1466, 1446, 1410, 1364,
1346, 1323, 1298, 1273, 1254, 1239, 1220, 1187, 1171, 1141, 1097,
1141, 1097, 1074, 1057, 1029, 982, 952, 935, 920, 895, 862, 845, 788,
766, 741, 700 cm−1.

(R)-tert-Butyl

(1-Benzyl-3-(nitromethyl)-2-oxoindolin-3-yl)-
carbamate (3a). Puriﬁed by ﬂash chromatography (petroleum
ether/EtOAc = 6:1) to aﬀord a white solid, 39.6 mg, 99% yield,
30 = −6.75 (c 1.42, CHCl3); HPLC
94% ee: mp 98−100 °C; [α]D
(DAICEL CHIRALCEL IA, n-hexane/2-propanol = 70/30, ﬂow rate
=1.0 mL/min, λ = 254 nm) tR 6.17 min (minor), 10.38 min (major);
1H NMR (CDCl3) δ 7.35 (d, J = 7.6 Hz, 1H), 7.32−7.11 (m, 6H),
6.96 (t, J = 7.6 Hz, 1H), 6.68 (d, J = 7.6 Hz, 1H), 5.96 (s, 1H), 5.03−
4.84 (m, 2H), 4.84−4.69 (m, 1H), 4.59 (d, J = 12.4 Hz, 1H), 1.27 (s,
9H); 13C NMR (CDCl3) δ 173.0, 153.8, 142.5, 135.1, 130.3, 128.9,
127.9, 127.4, 125.9, 124.5, 123.5, 110.0, 81.3, 77.8, 59.9, 44.5, 28.1;
HRMS (ESI-TOF) calcd for C21H23N3NaO5 ([M + Na+]) = 420.1530,
found 420.1531; IR (KBr) ν = 3300, 3031, 2984, 2913, 1706, 1611,
1556, 1533, 1487, 1466, 1418, 1367, 1353, 1337, 1288, 1254, 1223,
1223, 1162, 1020, 885, 824, 789, 767, 725 cm−1.

Ethyl

(1-Benzyl-3-(nitromethyl)-2-oxoindolin-3-yl)carbamate
(3b). Puriﬁed by ﬂash chromatography (petroleum ether/EtOAc =
6:1) to aﬀord a white solid, 33.2 mg, 90% yield, 85% ee: mp 106−108
30 = −8.94 (c 1.62, CHCl3); HPLC (DAICEL CHIRALCEL
°C; [α]D
IA, n-hexane/2-propanol = 70/30, ﬂow rate = 1.0 mL/min, λ = 254
nm) tR 6.75 min (minor), 9.31 min (major); 1H NMR (CDCl3) δ
7.44−7.18 (m, 7H), 7.04 (t, J = 7.6 Hz, 1H), 6.75 (d, J = 8 Hz, 1H),
6.33 (s, 1H), 5.05−4.88 (m, 3H), 4.66 (d, J = 12.4 Hz, 1H), 4.16−3.93
(m, 2H), 1.21 (s, 3H); 13C NMR (CDCl3) δ 172.74, 154.72, 142.62,
135.00, 130.52, 128.95, 127.90, 127.31, 125.46, 124.35, 123.57, 110.15,
77.80, 61.84, 59.91, 44.62, 14.33; HRMS (ESI-TOF) calcd for
C19H19N3NaO5 ([M + Na+]) = 392.1217, found 392.1218; IR (KBr) ν
= 3273, 3048, 1710, 1612, 1557, 1489, 1463, 1417, 1374, 1374, 1253,
1184, 1093, 1043, 807, 761, 739 cm−1.

Benzyl

(1-Benzyl-3-(nitromethyl)-2-oxoindolin-3-yl)carbamate
(3c). Puriﬁed by ﬂash chromatography (petroleum ether/EtOAc =
6:1) to aﬀord a white solid, 42.6 mg, 99% yield, 86% ee: mp 42−44
30 = −2.85 (c 1.41, CHCl3); HPLC (DAICEL CHIRALCEL
°C; [α]D
IA, n-hexane/2-propanol = 70/30, ﬂow rate = 1.0 mL/min) λ = 254
nm, tR: 8.93 min (minor), 13.36 min (major); 1H NMR (CDCl3) δ
7.49−7.15 (m, 12H), 7.08−7.00 (m, 1H), 6.73 (d, J = 7.8 Hz, 1H),
6.42 (s, 1H), 5.16−4.69 (m, 5H), 4.63 (d, J = 12.4 Hz, 1H); 13C NMR
(CDCl3) δ 172.6, 154.5, 142.6, 135.4, 134.9, 130.6, 128.9, 128.6, 128.5,
128.3, 127.9, 127.3, 125.3, 124.4, 123.6, 110.2, 77.7, 67.7, 59.9, 44.6;

HRMS (ESI-TOF) calcd for C24H21N3NaO5 ([M + Na+]) = 454.1373,
found 454.1382; IR (KBr) ν = 3308, 3032, 2923, 1957, 1726, 1612,
1559, 1491, 1468, 1455, 1426, 1374, 1252, 1183, 1051, 915, 845, 752
cm−1.

tert-Butyl

(1-Methyl-3-(nitromethyl)-2-oxoindolin-3-yl)-
carbamate (3d). Puriﬁed by ﬂash chromatography (petroleum
ether/EtOAc = 6:1) to aﬀord a white solid, 26.0 mg, 81% yield,
30 = −1.66 (c 1.08, CHCl3); HPLC
86% ee: mp 136−138 °C; [α]D
(DAICEL CHIRALCEL IA, n-hexane/2-propanol = 70/30, ﬂow rate =
1.0 mL/min, λ = 254 nm) tR 7.31 min (minor), 8.44 min (major); 1H
NMR (CDCl3) δ 7.49−7.31 (m, 2H), 7.14−7.06 (m, 1H), 6.90 (d, J =
7.6 Hz, 1H), 6.00 (s, 1H), 4.92 (d, J = 12.4 Hz, 1H), 4.60 (d, J = 12.4
Hz, 1H), 3.28 (s, 3H), 1.32 (s, 9H); 13C NMR (CDCl3) δ 172.7,
153.7, 143.3, 130.4, 125.9, 124.3, 123.5, 108.9, 81.2, 77.8, 59.9, 28.1,
26.9; HRMS (ESI-TOF) calcd for C15H19N3NaO5 ([M + Na+]) =
344.1217. Found 344.1217; IR (KBr) ν = 3341, 3011, 2968, 2927,
1704, 1612, 1563, 1519, 1491, 1471, 1408, 1370, 1320, 1255, 1162,
1128, 1107, 1054, 1028, 906, 874, 840, 778, 758, 724 cm−1.

tert-Butyl

(1-Benzyl-5-ﬂuoro-3-(nitromethyl)-2-oxoindolin-3-yl)-
carbamate (3e). Puriﬁed by ﬂash chromatography (petroleum
ether/EtOAc = 6:1) to aﬀord a white solid, 40.7 mg, 98% yield,
30 = −4.68 (c 0.790, CHCl3); HPLC
92% ee: mp 150−152 °C; [α]D
(DAICEL CHIRALCEL IA, n-hexane/2-propanol = 70/30, ﬂow rate =
1.0 mL/min, λ = 254 nm) tR 7.07 min (minor), 12.19 min (major); 1H
NMR (CDCl3) δ 7.41−7.23 (m, 6H), 6.94 (td, J = 8.8, 2.8 Hz, 1H),
6.68 (dd, J = 8.6, 4.0 Hz, 1H), 5.95 (s, 1H), 5.132−4.955 (m, 2H),
4.947−4.790 (m, 1H), 4.68 (d, J = 12.4 Hz, 1H), 1.38 (s, 9H); 13C
NMR (CDCl3) δ 172.8, 160.6, 158.2, 153.8, 138.5 (d, J = 2.2), 134.7,
129.0, 128.0, 127.3, 116.7 (d, J = 23.4), 113.1 (d, J = 26.1), 110.7 (d, J
= 7.9), 81.62, 77.4, 60.02, 44.7, 28.1; HRMS (ESI-TOF) calcd for
C21H22FN3NaO5 ([M + Na+]) = 438.1436, found 438.1437; IR (KBr)
ν = 3428, 3062, 3031, 2983, 2923, 1719, 1619, 1563, 1493, 1455, 1427,
1369, 1304, 1276, 1227, 1158, 1055, 993, 913, 882, 854, 821, 726
cm−1.

tert-Butyl

(1-Benzyl-5-chloro-3-(nitromethyl)-2-oxoindolin-3-yl)-
carbamate (3f). Puriﬁed by ﬂash chromatography (petroleum
ether/EtOAc = 6:1) to aﬀord a white solid, 42.7 mg, 99% yield,
30 = −27.5 (c 0.850, CHCl3); HPLC
91% ee: mp 156−158 °C; [α]D
(DAICEL CHIRALCEL IA, n-hexane/2-propanol = 70/30, ﬂow rate =
1.0 mL/min, λ = 254 nm) tR 6.82 min (minor), 11.66 min (major); 1H
NMR (CDCl3) δ 7.45 (d, J = 1.6 Hz, 1H), 7.39−7.27 (m, 5H), 7.21
(dd, J = 8.4, 2.0 Hz, 1H), 6.67 (d, J = 8.4 Hz, 1H), 5.96 (s, 1H), 5.08−
4.93 (m, 2H), 4.92−4.80 (m, 1H), 4.67 (d, J = 12.6 Hz, 1H), 1.38 (s,
9H); 13C NMR (CDCl3) δ 172.6, 153.8, 141.1, 134.6, 130.3, 129.0,
128.0, 127.5, 127.3, 125.1, 111.0, 81.68, 77.5, 59.8, 44.7, 28.2; HRMS
(ESI-TOF) calcd for C21H22Cl34.9689N3NaO5 ([M + Na+]) = 454.1140,
found 454.1145; C21H22Cl36.9659N3NaO5 ([M + Na+]) = 456.1111,
found 456.1130; IR (KBr) ν = 3427, 3031, 2977, 2925, 1720, 1610,
1564, 1488, 1429, 1369, 1296, 1277, 1159, 1055, 989, 875, 875, 849,
822, 776, 730 cm−1.

tert-Butyl

(1-Benzyl-5-bromo-3-(nitromethyl)-2-oxoindolin-3-yl)-
carbamate (3g). Puriﬁed by ﬂash chromatography (petroleum ether/
EtOAc = 6:1) to aﬀord a white solid, 46.6 mg, 98% yield, 91% ee: mp
30 = −36.1 (c 0.902, CHCl3); HPLC DAICEL
149−151 °C; [α]D
CHIRALCEL IA, n-hexane/2-propanol = 80/20, ﬂow rate = 1.0 mL/
min, λ = 254 nm, tR 6.98 min (minor), 11.99 min (major); 1H NMR
(CDCl3) δ 7.58 (s, 1H), 7.39−7.26 (m, 6H), 6.62 (d, J = 8.4 Hz, 1H),
5.98 (s, 1H), 5.055−4.926 (m, 2H), 4.931−4.811 (m, 1H), 4.67 (d, J =
12.6 Hz, 1H), 1.38 (s, 9H); 13C NMR (CDCl3) δ 172.5, 153.8, 141.6,
134.6, 133.2, 129.0, 128.1, 127.9, 127.7, 127.3, 116.2, 111.5, 81.7, 77.5,
59.8, 44.7, 28.2; HRMS (ESI-TOF) calcd for C21H22Br78.9183N3NaO5
([M + Na+]) = 498.0635, found 498.0646, C21H22Br80.9163N3NaO5
([M + Na+]) = 500.0615, found 500.0625; IR (KBr) ν = 3286, 3032,
2981, 2932, 1713, 1610, 1560, 1534, 1481, 1454, 1427, 1369, 1332,
1289, 1256, 1161, 1051, 1023, 1000, 875, 845, 813, 778, 719 cm−1.
(1-Benzyl-5-iodo-3-(nitromethyl)-2-oxoindolin-3-yl)-
carbamate (3h). Puriﬁed by ﬂash chromatography (petroleum
ether/EtOAc = 6:1) to aﬀord a white solid, 51.8 mg, 99% yield,
30 = −46.5 (c 1.81, CHCl3); HPLC
90% ee: mp 168−170 °C; [α]D
(DAICEL CHIRALCEL IA, n-hexane/2-propanol = 80/20, ﬂow rate =

tert-Butyl
</para>
3335

DOI: 10.1021/acs.joc.5b00075
J. Org. Chem. 2015, 80, 3332−3338

The Journal of Organic Chemistry

Note
<para sub=“exp”>
1.0 mL/min, λ = 254 nm) tR 7.37 min (minor), 12.68 min (major); 1H
NMR (CDCl3) δ 7.65 (s, 1H), 7.47 (d, J = 8.4 Hz, 1H), 7.33−7.13 (m,
5H), 6.45 (d, J = 8.0 Hz, 1H), 5.91 (s, 1H), 4.98−4.71 (m, 3H), 4.58
(d, J = 12.8 Hz, 1H), 1.30 (s, 9H); 13C NMR (CDCl3) δ 172.3, 153.8,
142.3, 139.2, 134.6, 133.1, 129.0, 128.1, 128.1, 127.3, 112.1, 86.0, 81.7,
77.5, 59.6, 44.6, 28.2; HRMS (ESI-TOF) calcd for C21H22IN3NaO5
([M + Na+]) = 546.0496, found 546.0502; IR (KBr) ν = 3287, 3031,
2981, 2927, 1712, 1607, 1558, 1535, 1479, 1453, 1424, 1366, 1331,
1290, 1257, 1161, 1045, 1022, 1000, 877, 815, 759, 715 cm−1.

tert-Butyl

(1-Benzyl-3-(nitromethyl)-2-oxo-5-(triﬂuoromethoxy)-
indolin-3-yl)carbamate (3i). Puriﬁed by ﬂash chromatography
(petroleum ether/EtOAc = 6:1) to aﬀord a white solid, 45.7 mg,
30 = −5.79 (c 0.518,
95% yield, 90% ee: mp 106−108 °C; [α]D
CHCl3); HPLC (DAICEL CHIRALCEL IA, n-hexane/2-propanol =
70/30, ﬂow rate = 1.0 mL/min, λ = 254 nm) tR 6.39 min (minor), 9.17
min (major); 1H NMR (CDCl3) δ 7.32 (s, 1H), 7.30−7.17 (m, 5H),
7.08−7.01 (m, 1H), 6.67 (d, J = 8.6 Hz, 1H), 5.87 (s, 1H), 5.00−4.90
(m, 2H), 4.80 (d, J = 16.0 Hz, 1H), 4.61 (d, J = 12.8 Hz, 1H), 1.29 (s,
9H); 13C NMR (CDCl3) δ 172.9, 153.8, 145.1 (d, J = 1.9), 141.3,
134.5, 129.0, 128.1, 127.4, 123.4, 120.4 (q, J = 255.6), 118.9, 110.5,
81.9, 59.9, 44.8, 28.1; HRMS (ESI-TOF) calcd for C22H22F3N3NaO6
([M + Na+]) = 504.1353, found 504.1363; IR (KBr) ν = 3306, 2990,
1723, 1684, 1621, 1561, 1496, 1454, 1437, 1418, 1396, 1372, 1341,
1257, 1218, 1166, 1082, 1055, 1024, 975, 928, 879, 854, 810, 743, 701
cm−1.

tert-Butyl (1-Benzyl-5-methyl-3-(nitromethyl)-2-oxoindolin-3-yl)-
carbamate (3j). Puriﬁed by ﬂash chromatography (petroleum ether/
EtOAc = 6:1) to aﬀord a white solid, 40.7 mg, 99% yield, 92% ee: mp
30 = −6.75 (c 1.42, CHCl3); HPLC (DAICEL
158−160 °C; [α]D
CHIRALCEL IA, n-hexane/2-propanol = 70/30, ﬂow rate = 1.0 mL/
min, λ = 254 nm) tR 7.21 min (minor), 14.94 min (major); 1H NMR
(CDCl3) δ 7.41−7.29 (m, 4H), 7.29−7.218 (m, 2H), 7.03 (d, J = 7.6
Hz, 1H), 6.64 (d, J = 8.0 Hz, 1H), 5.98 (s, 1H), 5.083−4.923 (m, 2H),
4.86 (d, J = 15.6 Hz, 1H), 4.65 (d, J = 12.4 Hz, 1H), 2.28 (s, 3H), 1.36
(s, 9H); 13C NMR (CDCl3) δ 172.8, 153.8, 140.0, 135.2, 133.2, 130.6,
128.9, 127.8, 127.4, 125.9, 125.1, 109.8, 81.2, 77.9, 60.0, 44.5, 28.2,
21.1; HRMS (ESI-TOF) calcd for C22H25N3NaO5 ([M + Na+]) =
434.1686, found 434.1688; IR (KBr) ν = 3317, 3032, 2975, 2926,
1703, 1622, 1607, 1563, 1528, 1499, 1452, 1428, 1368, 1315, 1280,
1250, 1199, 1165, 1032, 910, 861, 829, 780, 726 cm−1.

tert-Butyl

(1-Benzyl-6-chloro-3-(nitromethyl)-2-oxoindolin-3-yl)-
carbamate (3k). Puriﬁed by ﬂash chromatography (petroleum
ether/EtOAc = 6:1) to aﬀord a white solid, 42.3 mg, 98% yield,
30 = −9.71 (c 0.680, CHCl3); HPLC
94% ee: mp 132−134 °C; [α]D
(DAICEL CHIRALCEL IA, n-hexane/2-propanol = 80/20, ﬂow rate =
1.0 mL/min, λ = 254 nm) tR 6.15 min (minor), 9.61 min (major); 1H
NMR (CDCl3) δ 7.43−7.27 (m, 6H), 7.03 (dd, J = 8.0, 1.6 Hz, 1H),
6.76 (d, J = 1.4 Hz, 1H), 5.94 (s, 1H), 5.07−4.95 (m, 2H), 4.86 (d, J =
15.6 Hz, 1H), 4.63 (d, J = 12.4 Hz, 1H), 1.37 (s, 9H); 13C NMR
(CDCl3) δ 173.0, 153.8, 143.8, 136.3, 134.5, 129.1, 128.1, 127.3, 125.6,
124.2, 123.5, 110.7, 81.6, 77.6, 59.5, 44.7, 28.1; HRMS (ESI-TOF)
calcd for C21H22Cl34.9689N3NaO5 ([M + Na+]) = 454.1140, found
454.1148; C21H22Cl36.9659N3NaO5 ([M + Na+]) = 456.1111, found
456.1134; IR (KBr) ν = 3317, 3071, 3032, 2976, 2925, 1737, 1705,
1614, 1557, 1533, 1491, 1448, 1425, 1374, 1291, 1256, 1221, 1162,
1118, 1074, 1047, 1025, 1000, 914, 883, 844, 761, 718 cm−1.

tert-Butyl

(1-Benzyl-6-bromo-3-(nitromethyl)-2-oxoindolin-3-yl)-
carbamate (3l). Puriﬁed by ﬂash chromatography (petroleum ether/
EtOAc = 6:1) to aﬀord a white solid, 45.7 mg, 96% yield, 93% ee: mp
30 = −10.8 (c 0.814, CHCl3); HPLC (DAICEL
156−158 °C; [α]D
CHIRALCEL IA, n-hexane/2-propanol = 80/20, ﬂow rate = 1.0 mL/
min, λ = 254 nm) tR 6.24 min (minor), 9.76 min (major).1H NMR
(CDCl3) δ 7.38−7.27 (m, 6H), 7.16−7.21 (m, 1H), 6.91 (s, 1H), 5.95
(s, 1H), 5.03−4.95 (m, 2H), 4.86 (d, J = 15.7 Hz, 1H), 4.63 (d, J =
12.5 Hz, 1H), 1.37 (s, 9H); 13C NMR (CDCl3) δ 172.9, 153.8, 143.9,
134.5, 129.1, 128.1, 127.3, 126.4, 125.9, 124.8, 124.2, 113.4, 81.6, 77.5,
59.6, 44.7, 28.1; HRMS (ESI-TOF) calcd for C21H22Br78.9183N3NaO5
([M + Na+]) = 498.0635, found 498.0644, C21H22Br80.9163N3NaO5
([M + Na+]) = 500.0615, found 500.0627; IR (KBr) ν = 3320, 3066,
3032, 2976, 2932, 1736, 1705, 1608, 1555, 1532, 1488, 1452, 1441,

1423, 1372, 1290, 1256, 1221, 1163, 1119, 1060, 1025, 999, 912, 885,
840, 785, 761, 719 cm−1.

tert-Butyl

(1-Benzyl-7-ﬂuoro-3-(nitromethyl)-2-oxoindolin-3-yl)-
carbamate (3m). Puriﬁed by ﬂash chromatography (petroleum
ether/EtOAc = 6:1) to aﬀord a white solid, 41.1 mg, 99% yield,
30 = −7.18 (c 1.62, CHCl3); HPLC
93% ee: mp 54−56 °C; [α]D
(DAICEL CHIRALCEL IA, n-hexane/2-propanol = 70/30, ﬂow rate
=1.0 mL/min, λ = 254 nm) tR 6.83 min (minor), 13.31 min (major);
1H NMR (CDCl3) δ 7.40 (d, J = 7.4 Hz, 2H), 7.36−7.24 (m, 3H),
7.18 (d, J = 6.6 Hz, 1H), 7.08−6.94 (m, 2H), 6.09 (s, 1H), 5.09 (dd, J
= 38.9, 15.3 Hz, 2H), 4.91 (d, J = 12.5 Hz, 1H), 4.58 (d, J = 12.5 Hz,
1H), 1.34 (s, 9H); 13C NMR (CDCl3) δ 172.7, 153.7, 148.9, 146.5,
136.4, 129.2 (d, J = 9.1), 128.7, 127.8, 127.6, 124.3 (d, J = 6.4), 120.1,
118.6 (d, J = 19.4), 81.6, 77.8, 60.0 (d, J = 2.4), 46.2 (d, J = 4.8), 28.1;
HRMS (ESI-TOF) calcd for C21H22FN3NaO5 ([M + Na+]) =
438.1436, found 438.1441; IR (KBr) ν = 3339, 2979, 2933, 1721,
1632, 1604, 1561, 1490, 1425, 1368, 1279, 1250, 1162, 1060, 1025,
921, 858, 779, 731 cm−1.

tert-Butyl

(1-Benzyl-7-chloro-3-(nitromethyl)-2-oxoindolin-3-yl)-
carbamate (3n). Puriﬁed by ﬂash chromatography (petroleum
ether/EtOAc = 6:1) to aﬀord a white solid, 40.6 mg, 94% yield,
89% ee: mp 100−102 °C; [α]D
30 = +2.00 (c 0.802, CHCl3); HPLC
(DAICEL CHIRALCEL IA, n-hexane/2-propanol = 70/30, ﬂow rate =
1.0 mL/min, λ = 254 nm) tR 6.09 min (minor), 11.13 min (major); 1H
NMR (CDCl3) δ 7.37−7.28 (m, 5H), 7.27−7.22 (m, 2H), 7.00 (t, J =
7.8 Hz, 1H), 6.09 (s, 1H), 5.38 (dd, J = 16 Hz, J = 28.4 Hz, 2H), 4.90
(d, J = 12.4 Hz, 1H), 4.59 (d, J = 12.4 Hz, 1H), 1.36 (s, 9H); 13C
NMR (CDCl3) δ 173.6, 153.6, 138.7, 136.9, 133.0, 128.9, 128.7, 127.4,
126.6, 124.4, 122.6, 116.3, 81.6, 77.9, 59.5, 45.7, 28.1; HRMS (ESI-
TOF) calcd for C21H22Cl34.9689N3NaO5 ([M + Na+]) = 454.1140,
found 454.1140; C21H22Cl36.9659N3NaO5 ([M + Na+]) = 456.1111,
found 456.1128; IR (KBr) ν = 3327, 3065, 3031, 2977, 2936, 1937,
1713, 1612, 1559, 1520, 1457, 1423, 1364, 1335, 1281, 1255, 1159,
1082, 1022, 1001, 919, 873, 837, 819, 798, 779, 732 cm−1.

tert-Butyl

(1-Benzyl-7-bromo-3-(nitromethyl)-2-oxoindolin-3-yl)-
carbamate (3o). Puriﬁed by ﬂash chromatography (petroleum ether/
EtOAc = 6:1) to aﬀord a white solid, 47.1 mg, 99% yield, 90% ee: mp
126−128 °C; [α]D
30 = +4.75 (c 1.87, CHCl3); HPLC (DAICEL
CHIRALCEL IA, n-hexane/2-propanol = 70/30, ﬂow rate = 1.0 mL/
min, λ = 254 nm) tR 6.12 min (minor), 11.51 min (major); 1H NMR
(CDCl3) δ 7.36 (d, J = 8.4 Hz, 1H), 7.33−7.21 (m, 5H), 7.20−7.13
(m, 1H), 6.86 (t, J = 8.0 Hz, 1H), 6.01 (s, 1H), 5.35 (dd, J = 40.0, 16.4
Hz, 2H), 4.82 (d, J = 12.4 Hz, 1H), 4.51 (d, J = 12.4 Hz, 1H), 1.29 (s,
9H); 13C NMR (CDCl3) δ 173.8, 153.6, 140.1, 136.9, 136.4, 129.2,
128.7, 127.3, 126.5, 124.7, 123.2, 103.3, 81.7, 77.9, 59.4, 45.4, 28.1;
HRMS (ESI-TOF) calcd for C21H22Br78.9183N3NaO5 ([M + Na+]) =
498.0635, found 498.0646, C21H22Br80.9163N3NaO5 ([M + Na+]) =
500.0615, found 500.0625; IR (KBr) ν = 3327, 3064, 3030, 2977,
2934, 1712, 1609, 1558, 1519, 1453, 1422, 1364, 1335, 1282, 1255,
1255, 1158, 1124, 1082, 1022, 873, 829, 780, 731 cm−1.

tert-Butyl

(1-Benzyl-3-(nitromethyl)-2-oxo-7-(triﬂuoromethyl)-
indolin-3-yl)carbamate (3p). Puriﬁed by ﬂash chromatography
(petroleum ether/EtOAc = 6:1) to aﬀord a white solid, 43.7 mg,
30 = −9.56 (c 0.868,
94% yield, 89% ee: mp 124−126 °C; [α]D
CHCl3); HPLC (DAICEL CHIRALCEL IA, n-hexane/2-propanol =
70/30, ﬂow rate = 1.0 mL/min, λ = 254 nm) tR 6.15 min (minor),
10.31 min (major); 1H NMR (CDCl3) δ7.63−7.49 (m, 2H), 7.26−
7.07 (m, 6H), 5.97 (s, 1H), 5.14 (s, 2H), 4.82 (d, J = 12.4 Hz, 1H),
4.51 (d, J = 12.4 Hz, 1H), 1.28 (s, 9H); 13C NMR (CDCl3) δ 174.4,
153.6, 141.0, 135.7, 129.9, 128.3−128.6 (m), 127.8, 127.1, 125.9,
123.0, 113.7(q, J = 32.9), 81.8, 77.8, 58.3, 46.7, 46.7, 29.7, 28.1; HRMS
(ESI-TOF) calcd for C22H22F3N3NaO5 ([M + Na+]) = 488.1404,
found 488.1408; IR (KBr) ν = 3328, 3071, 3015, 2980, 2937, 1713,
1602, 1561, 1518, 1455, 1367, 1326, 1284, 1256, 1169, 1128, 1104,
1049, 1008, 919, 873, 819, 793, 748, 730, 705 cm−1.

tert-Butyl (1-Benzyl-5,7-dimethyl-3-(nitromethyl)-2-oxoindolin-3-
yl)carbamate (3q). Puriﬁed by ﬂash chromatography (petroleum
ether/EtOAc = 6:1) to aﬀord a white solid, 37.8 mg, 89% yield, 89%
30 = −20.5 (c 0.716, CHCl3); HPLC
ee: mp 130−132 °C; [α]D
(DAICEL CHIRALCEL IA, n-hexane/2-propanol = 80/20, ﬂow rate =
</para>
3336

DOI: 10.1021/acs.joc.5b00075
J. Org. Chem. 2015, 80, 3332−3338

The Journal of Organic Chemistry

Note
<para sub=“exp”>
1.0 mL/min, λ = 254 nm) tR 6.52 min (minor), 14.52 min (major); 1H
NMR (CDCl3) δ 7.36−7.21 (m, 6H), 7.07 (s, 1H), 6.83 (s, 1H), 6.06
(s, 1H), 5.18 (s, 2H), 4.88 (d, J = 12.0 Hz, 1H), 4.63 (d, J = 12.0 Hz,
1H), 2.25 (s, 3H), 2.21 (s, 3H), 1.38 (s, 9H); 13C NMR (CDCl3) δ
173.9, 153.8, 138.0, 137.2, 134.9, 133.2, 128.9, 127.3, 126.8, 125.9,
122.6, 120.3, 81.2, 78.4, 59.6, 45.8, 28.2, 20.8, 18.7; HRMS (ESI-TOF)
calcd for C23H27N3NaO5 ([M + Na+]) = 448.1852, found 448.1852;
IR (KBr) ν = 3445, 3031, 2980, 2925, 1719, 1604, 1566, 1487, 1414,
1366, 1326, 1274, 1254, 1157, 1050, 1028, 1002, 906, 867, 843, 771,
720 cm−1.

tert-Butyl (1-Benzyl-3-(1-nitroethyl)-2-oxoindolin-3-yl)carbamate
(3r). Puriﬁed by ﬂash chromatography (petroleum ether/EtOAc = 6:1)
to aﬀord a white solid, 40.7 mg, 99% yield, 65:35 dr 92%/93% ee: mp
92−94 °C; HPLC (DAICEL CHIRALCEL IA, n-hexane/2-propanol =
80/20, ﬂow rate = 1.0 mL/min, λ = 254 nm) tR 6.89 min (minor), 7.39
min (minor), 10.85 min (major), 17.74 min (major); 1H NMR
(CDCl3) δ 7.44−7.14 (m, 7H), 7.09−6.98 (m, 1H), 6.84−6.72 (m,
1H), 6.15 (d, J = 5.8 Hz, 1H), 5.19−4.66 (m, 3H), 1.72 (d, J = 6.9 Hz,
1H), 1.38−1.24 (m, 11H); 13C NMR (CDCl3) δ 173.4, 172.4, 153.9,
153.4, 143.4, 142.4, 135.4, 135.2, 130.2, 130.1, 128.9, 128.9, 127.9,
127.6, 127.4, 127.0, 124.7, 124.3, 123.4, 123.2, 123.2, 109.7, 109.5,
85.6, 84.8, 81.1, 62.7, 62.0, 44.7, 44.5, 28.1, 13.2, 13.0; HRMS (ESI-
TOF) calcd for C22H25N3NaO5 ([M + Na+]) = 434.1686,
found
434.1696; IR (KBr) ν = 3322, 3036, 2964, 2925, 2364, 1709, 1611,
1558, 1531, 1485, 1467, 1362, 1284, 1255, 1160, 1098, 1035, 1004,
976, 872, 843, 807, 758 cm−1.

3-Amino-1-benzyl-3-(nitromethyl)indolin-2-one (4). To a solution
of 3a (0.1 mmol, 39.7 mg) in CH2Cl2 (1.0 mL) was added CF3CO2H
(1.0 mL) at 0 °C. The mixture was allowed to stir for 2 h. Then the
mixture was neutralized with K2CO3, washed with brine, and dried
over Na2SO4. After evaporation of the solvent, the product 4 was
puriﬁed on silica gel chromatography (pet/EtOAc = 3/1) to aﬀord a
white solid, 28.5 mg, 96% yield, 94% ee: mp 58−60 °C; [α]D
30 =
−53.2 (c 0.528, CHCl3); HPLC (DAICEL CHIRALCEL ID, n-
hexane/2-propanol = 70/30, ﬂow rate = 1.0 mL/min, λ = 254 nm) tR
12.32 min (minor), 14.67 min (major); 1H NMR (CDCl3) δ 7.35−
7.12 (m, 7H), 6.99 (t, J = 7.6 Hz, 1H), 6.69 (d, J = 8.0 Hz, 1H), 4.96
(d, J = 15.6 Hz, 1H), 4.87−4.68 (m, 3H), 1.85 (s, 2H); 13C NMR
(CDCl3) δ 177.0, 143.0, 135.2, 130.5 128.9, 127.9, 127.3, 127.3, 123.9,
123.4, 110.2, 79.3, 59.0, 44.3, 29.7; HRMS (ESI-TOF) calcd for
C16H15N3NaO3 ([M + Na+]) = 320.1006, found 320.1008; IR (KBr) ν
= 3369, 3061, 3031, 2922, 1719, 1613, 1551, 1490, 1468, 1422, 1378,
1177, 1112, 1080, 991, 862, 753, 701 cm−1.

tert-Butyl

(3-(Aminomethyl)-1-benzyl-2-oxoindolin-3-yl)-
carbamate (5). To a solution of the compound 3a (0.2 mmol, 79.4
mg) in methanol (2.0 mL) at 0 °C was added NiCl2 (0.2 mmol, 25.8
mg) followed by NaBH4 (2.4 mmol, 90.7 mg) under nitrogen. The
mixture was stirred for 2 h. Then saturated aqueous NH4Cl (8 mL)
was added, and the mixture was extracted with CH2Cl2, washed with
brine, dried over MgSO4, and concentrated under reduced pressure.
The product 5 was puriﬁed on silica gel chromatography (pet/EtOAc
= 1/1) to aﬀord a white solid, 33.4 mg, 91% yield, 94% ee: mp 50−52
30 = −19.6 (c 1.08, CHCl3); HPLC (DAICEL CHIRALCEL
°C; [α]D
IA, n-hexane/2-propanol = 70/30, ﬂow rate =1.0 mL/min, λ = 254
nm) tR 7.11 min (minor), 10.13 min (major); 1H NMR (CDCl3) δ
7.40−7.22 (m, 6H), 7.21−7.14 (m, 1H), 7.02 (t, J = 7.6 Hz, 1H), 6.71
(d, J = 7.6 Hz, 1H), 6.28 (s, 1H), 5.13 (s, 1H), 4.77 (s, 1H), 3.02 (s,
2H), 1.82 (s, 2H), 1.26 (s, 9H); 13C NMR (CDCl3) δ 176.8, 154.6,
142.5, 135.9, 130.1, 128.8, 127.6, 127.3, 122.7, 122.5, 109.3, 80.3, 62.2,
48.4, 44.0, 29.7, 28.1; HRMS (ESI-TOF) calcd for C21H25N3NaO3
([M + H+]) = 368.1969, found 368.1971; IR (KBr) ν = 3343, 3060,
2969, 2930, 2866, 1718, 1615, 1467, 1365, 1279, 1172, 1075, 1005,
879, 749 cm−1.

tert-Butyl

(1-Benzyl-3-cyano-2-oxoindolin-3-yl)carbamate (6).
The compound 3a (0.3 mmol, 119.1) was added to a solution of
·2H2O (0.60 mmol, 136.0 mg), thiophenol (1.78 mmol, 183 μL),
SnCl2
and triethylamine (1.78 mmol, 247 μL) in absolute EtOH (2.0 mL) at
room temperature. After 20 min, the reaction mixture was poured into
1 M aqueous HCl (8 mL) and CH2Cl2 (10 mL) at 0 °C. The layers
were separated, and the aqueous layer was extracted with CH2Cl2 (3 ×

10 mL). The organic layer was washed with aqueous NaHCO3 (5 mL)
and brine (5 mL) and dried over MgSO4. After removal of the solvent,
the residue was chromatographed through a short plug of silica gel
eluting with pet/EtOAc = 3:1 to remove the excess thiophenol and
then with EtOAc. The EtOAc fraction was concentrated under
reduced pressure to give a stereoismeric mixture of oximes. To the
solution of oximes in THF (5.0 mL) at 0 °C under nitrogen
atmosphere were added triethylamine (1.12 mmol, 155 μL) and SOCl2
(0.34 mmol, 25 μL). After 45 min, water (8 mL) was added, and the
mixture was extracted with EtOAc (2 × 15 mL), washed with brine (3
mL), dried over MgSO4, and concentrated under reduced pressure.
Column chromatography eluting with pet/EtOAc = 5/1 gave the
compound 6 as a white solid, 78.3 mg, 75% yield, 93% ee: mp 58−60
°C; [α]D
30 = 72.4 (c 1.30, CHCl3); HPLC (DAICEL CHIRALCEL
ID, n-hexane/2-propanol = 90/10, ﬂow rate = 1.0 mL/min, λ = 254
nm) tR 30.19 min (major), 32.53 min (minor); 1H NMR (CDCl3) δ
7.73 (d, J = 7.6 Hz, 1H), 7.30−7.14 (m, 6H), 7.04 (t, J = 7.6 Hz, 1H),
6.67 (d, J = 8.0 Hz, 1H), 5.76 (s, 1H), 4.93−4.76 (m, 2H), 1.34 (s,
9H); 13C NMR (CDCl3) δ 168.3, 153.7, 142.2, 134.3, 131.2, 129.0,
128.1, 127.3, 126.2, 124.8, 124.3, 114.7, 110.3, 82.4, 54.9, 44.9, 28.1;
HRMS (ESI-TOF) calcd for C21H21N3NaO3 ([M + Na+]) = 386.1475,
found 386.1485; IR (KBr) ν = 3319, 3063, 2979, 2933, 2247, 2247,
1612, 1489, 1370, 1278, 1253, 1160, 1106, 1080, 1044, 1019, 940.96,
869, 753 cm−1.
</para>
■ ASSOCIATED CONTENT
*S Supporting Information
Full optimization details, 1H and 13C NMR spectra, and HPLC
data and X-ray crystal data of compounds 1d and 3a (CIF).
This material
is available free of charge via the Internet at
http://pubs.acs.org.

■ AUTHOR INFORMATION
Corresponding Authors
*E-mail: liuxh@scu.edu.cn.
*E-mail: xmfeng@scu.edu.cn.
Notes
The authors declare no competing ﬁnancial interest.

■ ACKNOWLEDGMENTS

We thank the National Natural Science Foundation of China
(21222206, 21321061), the Ministry of Education (NCET-11-
0345), and Fok Ying Tung Education Foundation (141115) for
ﬁnancial support.

■ REFERENCES
(1) For review on application of guanidines in organic synthesis, see:
(a) Ishikawa, T.; Kumamoto, T. Synthesis 2006, 737−752. Bicyclic
guanidine was shown to bind tightly to nitroalkanes to form an ion
pair, see: (b) Boyle, P. H.; Convery, M. A.; Davis, A. P.; Hosken, G.
D.; Murray, B. A. J. Chem. Soc., Chem. Commun. 1992, 239−242.
(c) van Aken, E.; Wynberg, H.; van Bolhuis, F. J. Chem. Soc., Chem.
Commun. 1992, 629−630. (d) Ishikawa, T. In Superbases for Organic
Synthesis; Ishikawa, T., Ed.; Wiley: Chichester, 2009; pp 93−143.
(e) Liu, X. H.; Lin, L. L.; Feng, X. M. Chem. Commun. 2009, 6145−
6158.
(2) For reviews on guanidium-based anionic receptors, see: (a) Best,
M. D.; Tobey, S. L.; Anslyn, E. V. Coord. Chem. Rev. 2003, 240, 3−15.
(b) Schug, K. A.; Lindner, W. Chem. Rev. 2005, 105, 67−113.
(c) Blondeau, P.; Segura, M.; Pérez-Fernández, R.; de Mendoza, J.
Chem. Soc. Rev. 2007, 36, 198−210.
(3) (a) Hannon, C. L.; Anslyn, E. V. In Bioorganic Chemistry
Frontiers; Dugas, H., Ed.; Springer-Verlag: Berlin, 1993; Vol. 3 pp
193−256. (b) Yamamoto, Y.; Kojima, S. In The Chemistry of Amidines
and Imidates; Patai, S., Rappoport, Z., Eds.; Wiley: New York, 1991;
Vol. 2, pp 485−526.

3337

DOI: 10.1021/acs.joc.5b00075
J. Org. Chem. 2015, 80, 3332−3338

The Journal of Organic Chemistry
(4) For selected reviews on guanidine-catalyzed reactions, see:
(a) Leow, D.; Tan, C.-H. Chem.Asian J. 2009, 4, 488−507.
(b) Terada, M. J. Synth. Org. Chem., Jpn. 2010, 68, 1159−1168. (c) Fu,
X.; Tan, C.-H. Chem. Commun. 2011, 47, 8210−8222. (d) Rauws, T.
R. M.; Maes, B. U. W. Chem. Soc. Rev. 2012, 41, 2463−2497.
(e) Taylor, J. E.; Bull, S. D.; Williams, J. M. J. Chem. Soc. Rev. 2012, 41,
2109−2121. (f) Selig, P. Synthesis 2013, 45, 703−718.
(5) For selected examples of guanidine-catalyzed reactions, see:
(a) Chinchilla, R.; Nájera, C.; Sánchez-Agulló, P. Tetrahedron:
Asymmetry 1994, 5, 1393−1402. (b) Ishikawa, T.; Araki, Y.;
Kumamoto, T.; Seki, H.; Fukuda, K.; Isobe, T. Chem. Commun.
2001, 245−246. (c) Terada, M.; Ube, H.; Yaguchi, Y. J. Am. Chem. Soc.
2006, 128, 1454−1455. (d) Sohtome, Y.; Hashimoto, Y.; Nagasawa, K.
Adv. Synth. Catal. 2005, 347, 1643−1648. (e) Corey, E. J.; Grogan, M.
J. Org. Lett. 1999, 1, 157−160. (f) Shen, J.; Nguyen, T. T.; Goh, Y.-P.;
Ye, W.; Fu, X.; Xu, J.; Tan, C.-H. J. Am. Chem. Soc. 2006, 128, 13692−
13693. (g) Misaki, T.; Takimoto, G.; Sugimura, T. J. Am. Chem. Soc.
2010, 132, 6286−6287. (h) Fu, X.; Loh, W.-T.; Zhang, Y.; Chen, T.;
Ma, T.; Liu, H.; Wang, J.; Tan, C.-H. Angew. Chem., Int. Ed. 2009, 48,
7387−7390.
(6) (a) Yu, Z. P.; Liu, X. H.; Zhou, L.; Lin, L. L.; Feng, X. M. Angew.
Chem., Int. Ed. 2009, 48, 5195−5198. (b) Dong, S. X.; Liu, X. H.;
Chen, X. H.; Mei, F.; Zhang, Y. L.; Gao, B.; Lin, L. L.; Feng, X. M. J.
Am. Chem. Soc. 2010, 132, 10650−10651. (c) Dong, S. X.; Liu, X. H.;
Zhang, Y. L.; Lin, L. L.; Feng, X. M. Org. Lett. 2011, 13, 5060−5063.
(d) Xiao, X.; Liu, X. H.; Dong, S. X.; Cai, Y. F.; Lin, L. L.; Feng, X. M.
Chem.Eur. J. 2012, 18, 15922−15926. (e) Yang, Y.; Dong, S. X.; Liu,
X. H.; Lin, L. L.; Feng, X. M. Chem. Commun. 2012, 48, 5040−5042.
(f) Dong, S. X.; Liu, X. H.; Zhu, Y.; He, P.; Lin, L. L.; Feng, X. M. J.
Am. Chem. Soc. 2013, 135, 10026−10029. (g) Zhu, Y.; Liu, X. H.;
Dong, S. X.; Zhou, Y. H.; Li, W.; Lin, L. L.; Feng, X. M. Angew. Chem.,
Int. Ed. 2014, 53, 1636−1640.
(7) For selected reviews about aza-Henry reactions, see: (a) West-
ermann, B. Angew. Chem., Int. Ed. 2003, 42, 151−153. (b) Marqués-
López, E.; Merino, P.; Tejero, T.; Herrera, R. P. Eur. J. Org. Chem.
2009, 2401−2420. (c) Noble, A.; Anderson, J. C. Chem. Rev. 2013,
113, 2887−2939.
(8) (a) Yamada, K.-i; Harwood, S. J.; Gröger, H.; Shibasaki, M.
Angew. Chem., Int. Ed. 1999, 38, 3504−3506. (b) Knudsen, K. R.;
Risgaard, T.; Nishiwaki, N.; Gothelf, K. V.; Jørgensen, K. A. J. Am.
Chem. Soc. 2001, 123, 5843−5844. (c) Nishiwaki, N.; Knudsen, K. R.;
Gothelf, K. V.; Jørgensen, K. A. Angew. Chem., Int. Ed. 2001, 40, 2992−
2995. (d) Palomo, C.; Oiarbide, M.; Halder, R.; Laso, A.; López, R.
Angew. Chem., Int. Ed. 2006, 45, 117−120. (e) Chen, Z.; Morimoto,
H.; Matsunaga, S.; Shibasaki, M. J. Am. Chem. Soc. 2008, 130, 2170−
2171. (f) Nugent, B. M.; Yoder, R. A.; Johnston, J. N. J. Am. Chem. Soc.
2004, 126, 3418−3419. (g) Yoon, T. P.; Jacobsen, E. N. Angew. Chem.,
Int. Ed. 2005, 44, 466−468. (h) Singh, A.; Yoder, R. A.; Shen, B.;
Johnston, J. N. J. Am. Chem. Soc. 2007, 129, 3466−3467. (i) Wang, C.-
J.; Dong, X.-Q.; Zhang, Z.-H.; Xue, Z.-Y.; Teng, H.-L. J. Am. Chem. Soc.
2008, 130, 8606−8607. (j) Singh, A.; Johnston, J. N. J. Am. Chem. Soc.
2008, 130, 5866−5867.
(9) For examples of nitro-Mannich reaction of ketimines, see:
(a) Tan, C.; Liu, X. H.; Wang, L. W.; Wang, J.; Feng, X. M. Org. Lett.
2008, 10, 5305−5308. (b) Xie, H.; Zhang, Y.; Zhang, S.; Chen, X.;
Wang, W. Angew. Chem., Int. Ed. 2011, 50, 11773−11776. (c) Parra,
A.; Alfaro, R.; Marzo, L.; Moreno-Carrasco, A.; Ruano, J. L. G.;
Alemán, J. Chem. Commun. 2012, 48, 9759−9761. (d) Núñez, M. G.;
Farley, A. J. M.; Dixon, D. J. J. Am. Chem. Soc. 2013, 135, 16348−
16351.
(10) (a) Lin, H.; Danishefsky, S. J. Angew. Chem., Int. Ed. 2003, 42,
36−51. (b) Zhou, F.; Liu, Y.-L.; Zhou, J. Adv. Synth. Catal. 2010, 352,
1381−1407. (c) Galliford, C. V.; Scheidt, K. A. Angew. Chem., Int. Ed.
2007, 46, 8748−8758. (d) Bernard, K.; Bogliolo, S.; Ehrenfeld, J. Br. J.
Pharmacol. 2005, 144, 1037−1050. (e) Claudine, S-L. G.; Sylvain, D.;
Gabrielle, B.; Maurice, M.; Jacques, S.; Rolf, G.; Guy, G.; Gilles, G.
Stress 2003, 6, 199−206. (f) Horoszok, L.; Leung, C.; Tomaszewski,
M.; Walpole, C. PCT Int. Appl. WO2007091946, 2007. (g) Shen, K.;
Liu, X. H.; Lin, L. L.; Feng, X. M. Chem. Sci. 2012, 3, 327−334.

Note

(11) (a) Lesma, G.; Landoni, N.; Pilati, T.; Sacchetti, A.; Silvani, A. J.
Org. Chem. 2009, 74, 4537−4541. (b) Mouri, S.; Chen, Z.;
Mitsunuma, H.; Furutachi, M.; Matsunaga, S.; Shibasak, M. J. Am.
Chem. Soc. 2010, 132, 1255−1257. (c) Jung, H. H.; Buesking, A. W.;
Ellman, J. A. Org. Lett. 2011, 13, 3912−3915. (d) Shen, K.; Liu, X. H.;
Wang, G.; Lin, L. L.; Feng, X. M. Angew. Chem., Int. Ed. 2011, 50,
4684−4688. (e) Yang, Z. G.; Wang, Z.; Bai, S.; Shen, K.; Chen, D. H.;
Liu, X. H.; Lin, L. L.; Feng, X. M. Chem.Eur. J. 2010, 16, 6632−
6637. (f) Lesma, G.; Meneghetti, F.; Sacchetti, A.; Stucchi, M.; Silvani,
A. Beilstein J. Org. Chem. 2014, 10, 1383−1389.
(12) (a) Arai, T.; Matsumura, E.; Masu, H. Org. Lett. 2014, 16,
2768−2771. (b) Holmquist, M.; Blay, G.; Pedro, J. R. Chem. Commun.
2014, 50, 9309−9312.
(13) (a) Wang, Y.-H.; Liu, Y.-L.; Cao, Z.-Y.; Zhou, J. Asian J. Org.
Chem. 2014, 3, 429−432. (b) Wang, Y.-H.; Cao, Z.-Y.; Niu, Y.; Zhao,
X.; Zhou, J. Acta. Chim. Sin. 2014, 72, 867−872.
(14) Kumar, A.; Kaur, J.; Chimni, S. S.; Jassal, A. K. RSC Adv. 2014,
4, 24816−24819.
(15) CCDC 1034682 (3a) and CCDC 1034663 (1d) contain the
supplementary crystallographic data for this paper. These data can be
obtained free of charge from the Cambridge Crystallographic Data
Centre via www.ccdc.cam.ac.uk./data_request/cif.
(16) Wei, Y.; He, W.; Liu, Y.; Liu, P.; Zhang, S. Org. Lett. 2012, 14,
704−707.
(17) Sacchetti, A.; Silvani, A.; Gatti, F. G.; Lesma, G.; Pilati, T.;
Trucchi, B. Org. Biomol. Chem. 2011, 9, 5515−5522.
(18) The product was generated in 91% yield, 30% ee by the use of
1f as the catalyst.

3338

DOI: 10.1021/acs.joc.5b00075
J. Org. Chem. 2015, 80, 3332−3338

